📣 VC round data is live. Check it out!
- Public Comps
- OraSure
OraSure Valuation Multiples
Discover OraSure's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Carlsmed, Ascom, Australian Clinical Labs, Quantum-Si and more.
OraSure Overview
About OraSure
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
Founded
2000
HQ

Employees
501
Website
Financials (LTM)
EV
$111M
Valuation Multiples
Start free trialOraSure Financials
OraSure reported last 12-month revenue of $117M and negative EBITDA of ($40M).
In the same LTM period, OraSure generated $49M in gross profit, ($40M) in EBITDA losses, and had net loss of ($71M).
Revenue (LTM)
OraSure P&L
In the most recent fiscal year, OraSure reported revenue of $115M and EBITDA of ($42M).
OraSure is unprofitable as of last fiscal year, with gross margin of 42%, EBITDA margin of (36%), and net margin of (60%).
Financial data powered by Morningstar, Inc.
OraSure Stock Performance
OraSure has current market cap of $275M, and enterprise value of $111M.
Market Cap Evolution
OraSure's stock price is $4.00.
OraSure share price decreased by 6.8% in the last 30 days, and increased by 33.3% in the last year.
OraSure has an EPS (earnings per share) of $-1.00.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $111M | $275M | -2.6% | -6.8% | 33.3% | 33.3% | $-1.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOraSure Valuation Multiples
OraSure trades at 0.9x EV/Revenue multiple, and (2.7x) EV/EBITDA.
EV / Revenue (LTM)
OraSure Financial Valuation Multiples
As of June 3, 2026, OraSure has market cap of $275M and EV of $111M.
OraSure has a P/E ratio of (3.9x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified OraSure Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


OraSure Margins & Growth Rates
OraSure grew revenue by 4% but EBITDA decreased by 8% in the last fiscal year.
In the most recent fiscal year, OraSure reported gross margin of 42%, EBITDA margin of (36%), and net margin of (60%).
OraSure Margins
OraSure Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
OraSure Operational KPIs
OraSure's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
OraSure's Rule of 40 is (28%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
OraSure's Rule of X is (22%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
OraSure Competitors
OraSure competitors include Carlsmed, Ascom, Australian Clinical Labs, Quantum-Si, Shoulder Innovations, Eurobio Scientific, Medipost, Carvolix, Median Technologies and SmartVest.
Most OraSure public comparables operate across Medical Devices, Laboratory Services, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.9x | 3.2x | (7.1x) | (6.4x) | |||
| 0.7x | 0.7x | 5.9x | 6.0x | |||
| 0.9x | 0.9x | 3.5x | 3.4x | |||
| 58.8x | 77.6x | (1.8x) | (1.7x) | |||
| 4.2x | 3.5x | (5.4x) | (5.9x) | |||
| 1.3x | 1.3x | 7.8x | 7.3x | |||
| 5.2x | - | (4.8x) | - | |||
| 57.0x | 401.8x | (19.6x) | (12.8x) | |||
This data is available for Pro users. Sign up to see all OraSure competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by OraSure
OraSure has acquired 6 companies to date.
Last acquisition by OraSure was on November 4th 2025. OraSure acquired BioMedomics for $4M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by OraSure
| Description | BioMedomics is a bioscience manufacturer producing DNA reagents, antibodies, tissue arrays, and cell assay kits. Research Triangle Park-based in North Carolina, it develops real-time electronic sensing for proliferation and invasion assays, serving academic labs and drug developers. | Sherlock Biosciences is a molecular diagnostics company developing CRISPR-based tests for infectious diseases and beyond. Cambridge, Massachusetts-headquartered and founded in 2019, Sherlock combines SHERLOCK and INSPECTR platforms for point-of-care detection of pathogens like SARS-CoV-2 and antibiotic resistance genes. The company partners with the Broad Institute and has received BARDA funding for rapid diagnostic kits deployable in low-resource settings. | UrSure is a diagnostics company developing point-of-care tests to monitor medication adherence, starting with HIV prevention and treatment drugs like PrEP and antiretrovirals. San Francisco-based, its assays provide rapid results to improve patient outcomes in global health initiatives. | Diversigen is a microbiome analysis company headquartered in Minneapolis, Minnesota. It offers sequencing, bioinformatics, and consulting for human, animal, and environmental samples using shotgun metagenomics on Illumina platforms. Services detect microbes at species level with custom pipelines for research in gut health and agriculture. Founded in 2014 as part of the University of Minnesota ecosystem, it processes thousands of samples yearly for clients like Mayo Clinic. | |
| HQ Country | |||||
| HQ City | Raleigh, NC | - | Boston, MA | Houston, TX | |
| Deal Date | 4 Nov 2025 | 19 Dec 2024 | 29 May 2020 | 6 Nov 2019 | |
| Valuation | $4M | $5M | $3M | $12M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all OraSure acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Investments by OraSure
OraSure has invested in 1 company to date.
Latest investment by OraSure was on January 4th 2024. OraSure invested in Sapphiros in their $30M Series B round (EV/Revenue multiple available to Pro users).
Latest Investments by OraSure
| Description | Sapphiros is a venture firm investing in growth-stage diagnostics companies emphasizing patient-centric technologies. Headquartered in San Francisco, it backs innovations in sample collection, next-generation sequencing, computational biology, and printed electronics. The portfolio enables accessible diagnostic testing for consumers worldwide, supporting startups that address gaps in global healthcare delivery. |
| HQ Country | |
| HQ City | Boston, MA |
| Deal Date | 4 Jan 2024 |
| Round | Series B |
| Raised | $30M |
| Investors | OraSure |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all OraSure investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout OraSure
| When was OraSure founded? | OraSure was founded in 2000. |
| Where is OraSure headquartered? | OraSure is headquartered in United States. |
| How many employees does OraSure have? | As of today, OraSure has over 501 employees. |
| Who is the CEO of OraSure? | OraSure's CEO is Carrie Eglinton Manner. |
| Is OraSure publicly listed? | Yes, OraSure is a public company listed on Nasdaq. |
| What is the stock symbol of OraSure? | OraSure trades under OSUR ticker. |
| When did OraSure go public? | OraSure went public in 1986. |
| Who are competitors of OraSure? | OraSure main competitors include Carlsmed, Ascom, Australian Clinical Labs, Quantum-Si, Shoulder Innovations, Eurobio Scientific, Medipost, Carvolix, Median Technologies, SmartVest. |
| What is the current market cap of OraSure? | OraSure's current market cap is $275M. |
| What is the current revenue of OraSure? | OraSure's last 12 months revenue is $117M. |
| What is the current revenue growth of OraSure? | OraSure revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of OraSure? | Current revenue multiple of OraSure is 0.9x. |
| Is OraSure profitable? | No, OraSure is not profitable. |
| What is the current EBITDA of OraSure? | OraSure has negative EBITDA and is not profitable. |
| What is OraSure's EBITDA margin? | OraSure's last 12 months EBITDA margin is (35%). |
| What is the current EV/EBITDA multiple of OraSure? | Current EBITDA multiple of OraSure is (2.7x). |
| How many companies OraSure has acquired to date? | As of June 2026, OraSure has acquired 6 companies. |
| What was the largest acquisition by OraSure? | $12M acquisition of Diversigen on 6th November 2019 was the largest M&A OraSure has done to date. |
| What companies OraSure acquired? | OraSure acquired Diversigen, Sherlock Biosciences, BioMedomics, UrSure, CoreBiome, and Novosanis NV. |
| In how many companies OraSure has invested to date? | As of June 2026, OraSure has invested in 1 company. |
| What was the last OraSure investment? | On 4th January 2024 OraSure invested in Sapphiros, participating in a $30M Series B round. |
| In what companies OraSure invested in? | OraSure invested in Sapphiros. |
See public comps similar to OraSure
Lists including OraSure
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
